According to Towards FnB, the global fruit and vegetables market size is evaluated at USD 244 billion in 2025 and is forecasted to hit around USD 388.37 billion by 2034, growing at a CAGR of 5.3% during the forecast period from 2025 to 2034.
According to Towards FnB, the global fruit and vegetables market size is evaluated at USD 244 billion in 2025 and is forecasted to hit around USD 388.37 billion by 2034, growing at a CAGR of 5.3% during the forecast period from 2025 to 2034.
AI Agents That Build and Manage Infrastructure at the Speed of AI-Driven Development
SAN FRANCISCO, July 29, 2025 /PRNewswire/ -- StackGen, the pioneer in autonomous infrastructure...
New PSA invites supporters to give back by giving backpacks to girls around the world
WASHINGTON, July 28, 2025 /PRNewswire/ -- Plan International and Paramount,...
VYJUVEK approved for the treatment of DEB from birth with flexible administration options including home dosing and the option for administration by the patient or their family
BEIJING, July 24, 2025 /PRNewswire/ -- Life has never been happier for Xu Furong.
The 86-year-old resident of Nanliuzhuang village starts each morning with a bit of...
Dr. Adelola Ashaye has launched Metabolic Wellness & Healthy Weight Program at InTouch Primary Care, offering a personalized, medically guided approach to sustainable weight loss...
Hennigsdorf/ Berlin, July 23, 2025 – 4TEEN4 Pharmaceuticals GmbH today announced that the first patient has been dosed in a Phase 1b/2a PROCARD1 clinical trial evaluating its monoclonal antibody, procizumab, in patients with shock caused primarily by cardiogenic events. Shock is a life-threatening condition characterized by a sudden breakdown in circulatory function due to end-stage disease or acute events, which often leads to organ failure. With only symptomatic treatment options available, shock is associated with a high mortality rate of over 50%. The Phase 1b/2a trial is designed to identify a target dose for procizumab in preparation for further clinical development. In addition, the trial will provide signals of efficacy. In a Phase 1 study in healthy volunteers, procizumab was well tolerated.
LOS ANGELES, July 23, 2025 /PRNewswire/ -- Viewers of Public Television are in for an enlightening experience as "Empowered with Meg Ryan" presents a...
BEIJING, July 22, 2025 /PRNewswire/ -- Editor's Note:
Chinese people believe that letters are as valuable as gold. For thousands of years, letters, across mountains...
The "Switch Your Story" campaign is Schwarzkopf's first-ever collaboration with The Walt Disney Studios
LOS ANGELES, July 22, 2025 /PRNewswire/ -- Schwarzkopf®, an authority in hair...
Alzheimer's disease affects more than 6 million Americans, and emerging research identifies Obstructive Sleep Apnea (OSA) as a significant, modifiable risk factor. Interrupted breathing...
MACAU, July 22, 2025 /PRNewswire/ -- In July's high summer season, the "Art Macao: Macao International Art Biennale 2025" has kicked off and the Special...
New York City, NY, July 21, 2025 (GLOBE NEWSWIRE) -- PhenQ is leading the 2025 weight loss revolution with a science-backed natural appetite suppressant—no needles, no harsh side effects, just sustainable, healthy weight control
SHENZHEN, China, July 21, 2025 /PRNewswire/ -- From September 1 to 3, 2025, SIAL Shenzhen 2025, an exclusive gateway to South Asia's dynamic food and...